Sarepta (SRPT) on Soars 15.7% on 5th Day Ahead of Clinical Trial Results

We recently published 10 Stocks With Double-Digit Upsides. Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the top performers on Thursday. Sarepta Therapeutics extended its winning streak to a 5th consecutive day on Thursday, surging 15.68 percent to close at $22.35 apiece as investors repositioned portfolios ahead of the upcoming preliminary results for a drug clinical trial to treat myotonic dystrophy type 1 (DM1). Earlier this year, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) said that it would announ ...